Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;1(2):23-30.
doi: 10.33696/Signaling.1.006. Epub 2020 May 5.

COVID-19 Clinical Research

Jeffrey Chi  1 , David Chitty  1 , Meeyoung Lee  1 , Nausheen Hakim  1 , Shamsah Lakhani  1 , Lakshmi Rajdev  1 , Xinhua Zhu  1 , Muhammad Wasif Saif  1
Affiliations

COVID-19 Clinical Research

Jeffrey Chi et al. J Cell Signal. 2020 Jun.

Abstract

Introduction: While the global COVID-19 pandemic has challenged the entire humanity and health systems, it also triggered researchers to urgently perform clinical trials to assess the safety and efficacy of many agents and modalities to combat COVID-19. As of April 22, over 650 clinical studies have been registered both in USA and internationally. Results from these studies are also coming at a brisk pace in this unprecedented emergency.

Areas covered: We searched the NCI website and Medline and summarize various national and international clinical trials and summarize few of the pivotal ones in this paper, including those specific to oncology population. Two hundred and eighty four studies are actively recruiting adults and children with confirmed COVID-19, including 25 are early-phase I/phase I, 72 phase II, 58 phase III, 12 phase IV, and 31 other trials. They can be categorized into four groups: drugs that combat SARS-CoV-2, immunomodulatory agents to counteract cytokine storm, convalescence plasma therapies and vaccines trials.

Expert opinion: It is hoped that these efforts will results in a successful treatment to COVID-19, especially in a timely fashion before the second pandemic expected in fall. It is essential to acknowledge the devotion and hard work of the clinical research team and clinical research volunteers.

Keywords: BCG; COVID-19; Convalescent plasma; Cytokine storm; Immunomodulatory; Immunosuppression; SARS-CoV-2; Vaccines.

PubMed Disclaimer

References

    1. COVID-19 Map [Internet]. Johns Hopkins Coronavirus Resource Center. [cited 2020 Apr 22]. Available from: https://coronavirus.jhu.edu/map.html
    1. Garg S Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep [Internet]. 2020. [cited 2020 Apr 22];69 Available from: https://www.cdc.gov/mmwr/volumes/69/wr/mm6915e3.htm - PMC - PubMed
    1. Imbalanced host response to SARS-CoV-2 drives development of COVID-19 — Immunology [Internet]. [cited 2020 Apr 25]. Available from: https://www.immunology.ox.ac.uk/covid-19/literature-digest/imbalanced-ho... - PMC - PubMed
    1. Cao X COVID-19: immunopathology and its implications for therapy. Nature Reviews Immunology. 2020. May;20(5):269–70. - PMC - PubMed
    1. Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virology Journal. 2005. December 1;2(1):69. - PMC - PubMed

LinkOut - more resources